Brief: Anika Therapeutics Reports Q4 2020 Financial Results

Anika Therapeutics

04/03/2021 22:37

March 4 (Reuters) - Anika Therapeutics Inc  ANIK.O :
    * Q4 ADJUSTED EARNINGS PER SHARE $0.12
    * Q4 LOSS PER SHARE $1.10
    * Q4 REVENUE ROSE 10 PERCENT TO $32.7 MILLION

Source text for Eikon:  ID:nGNX6sjRtq 
Further company coverage:  ANIK.O 

 ((Reuters.Briefs@thomsonreuters.com;))